Why the study?
Does the use of thrombolytic and antiplatelet drugs reduce 28-day case fatality in patients hospitalized with a first Q-wave acute myocardial infarction?
Population
2053 consecutive patients 25 to 74 years of age with a first Q-wave acute myocardial infarction admitted to…
Comparison
Thrombolytic and antiplatelet drugs vs Prethrombolytic therapy periods
Design
Cohort
Follow-up
28 days
Authors
Loading...
Supports association of thrombolytic/antiplatelet adoption with lower 28-day fatality in first Q-wave MI; leaves causal effect open.
Does the use of thrombolytic and antiplatelet drugs reduce 28-day case fatality in patients hospitalized with a first Q-wave acute myocardial infarction?
The introduction and routine use of thrombolytic and antiplatelet drugs significantly reduced 28-day case fatality in patients hospitalized with a first Q-wave acute myocardial infarction.
Gil et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: